Rifapentine and isoniazid for prevention of tuberculosis in people with diabetes (PROTID): protocol for a randomised controlled trial
DiscussionPROTID is anticipated to generate key evidence to guide decisions over the use of TB preventive treatment among people with DM as an important target group for better global TB control.Trial registrationClinicalTrials.govNCT04600167. Registered on 23 October 2020 (Source: Trials)
Source: Trials - June 10, 2022 Category: Research Source Type: clinical trials
Reducing the risk of Plasmodium vivax after falciparum infections in co-endemic areas —a randomized controlled trial (PRIMA)
This study evaluates the potential benefit of a universal radical cure for bothP. vivax andP. falciparum in different endemic locations. If found safe and effective universal radical cure could represent a cost-effective approach to clear otherwise unrecognisedP. vivax infections and hence accelerateP. vivax elimination.Trial registrationNCT03916003. Registered on 12 April 2019. (Source: Trials)
Source: Trials - May 18, 2022 Category: Research Source Type: clinical trials
Adoption of L-PZQ for Schistosomiasis by Endemic Counties - Social Science Research Study
Conditions: Schistosomiasis in Children; Social Acceptance Intervention: Behavioral: Community pilot L-PZQ distribution - intervention is NOT part of this observational study Sponsors: Technische Universität München; African Institute for Health and Development; Makerere University; European and Developing Countries Clinical Trials Partnership (EDCTP); Global Health Innovation Technology Fund (GHIT); Stichting Lygature; Université Félix Ho uphouët-Boigny; Kenya Medical Research Institute; Swiss Tropical & Public Health Institute; SCI Foundation Recruit...
Source: ClinicalTrials.gov - April 28, 2022 Category: Research Source Type: clinical trials
Dengue Vaccine Hesitancy and Acceptance in Endemic Regions of Argentina: Impact of Communication Strategies
Condition: Dengue Intervention: Sponsor: Fundacion GESICA Not yet recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - January 28, 2022 Category: Research Source Type: clinical trials
